| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| ATAD5 protein, partial | 7 | 0 | 0 | 7 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
| chromobox protein homolog 1 | 12 | 0 | 0 | 12 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| geminin | 13 | 0 | 0 | 13 |
| lethal factor (plasmid) | 3 | 0 | 1 | 4 |
| botulinum neurotoxin type A | 0 | 0 | 1 | 1 |
| botulinum neurotoxin type F, BoNT/F | 0 | 0 | 1 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| GLS protein | 4 | 0 | 0 | 4 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 4 | 0 | 0 | 4 |
| ATP-dependent phosphofructokinase | 8 | 0 | 0 | 8 |
| DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Integrin alpha-5 | 0 | 1 | 0 | 1 |
| Integrin beta-5 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| interleukin 8 | 4 | 0 | 0 | 4 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| RAR-related orphan receptor gamma | 12 | 0 | 0 | 12 |
| Fumarate hydratase | 7 | 0 | 0 | 7 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| PPM1D protein | 5 | 0 | 0 | 5 |
| TDP1 protein | 15 | 0 | 0 | 15 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| AR protein | 13 | 0 | 0 | 13 |
| Smad3 | 1 | 0 | 0 | 1 |
| aldehyde dehydrogenase 1 family, member A1 | 9 | 0 | 0 | 9 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
| glucocorticoid receptor [Homo sapiens] | 10 | 0 | 0 | 10 |
| retinoic acid nuclear receptor alpha variant 1 | 11 | 0 | 0 | 11 |
| retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
| estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
| estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
| polyprotein | 7 | 0 | 0 | 7 |
| 67.9K protein | 6 | 0 | 0 | 6 |
| Parkin | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| arylsulfatase A | 4 | 0 | 0 | 4 |
| IDH1 | 4 | 0 | 0 | 4 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| activating transcription factor 6 | 7 | 0 | 0 | 7 |
| Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
| peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform 2 | 8 | 0 | 0 | 8 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 6 | 0 | 0 | 6 |
| Interferon beta | 11 | 0 | 0 | 11 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| Adenosine receptor A3 | 0 | 5 | 0 | 5 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
| Ataxin-2 | 7 | 0 | 0 | 7 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
| Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
| oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
| survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
| Voltage-dependent calcium channel gamma-2 subunit | 6 | 0 | 0 | 6 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 6 | 0 | 0 | 6 |
| Thymidine phosphorylase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
| EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 0 | 0 | 4 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 10 | 0 | 10 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 0 | 2 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 3 | 3 | 13 |
| DNA topoisomerase 2-alpha | 0 | 3 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 0 | 0 | 4 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 0 | 0 | 4 |
| Somatostatin receptor type 1 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 2 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 4 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 3 | 0 | 2 | 0 | 2 |
| Somatostatin receptor type 5 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 0 | 0 | 4 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| DNA topoisomerase 2-beta | 0 | 2 | 1 | 10 |
| DNA topoisomerase 1 | 0 | 2 | 0 | 3 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 2 | 0 | 2 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 4 | 0 | 0 | 4 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 10 | 0 | 11 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 0 | 0 | 4 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| GALC protein | 3 | 0 | 0 | 3 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 2 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 2 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 4 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| G | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 1 | 2 | 0 | 3 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Interstitial collagenase | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 6 | 1 | 7 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 3 | 0 | 0 | 3 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 4 |
| Cytochrome P450 3A4 | 0 | 4 | 1 | 5 |
| Cytochrome P450 2C9 | 0 | 3 | 1 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| unnamed protein product | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Cytochrome P450 144 | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Mycocyclosin synthase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| Luciferase | 5 | 0 | 0 | 5 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| Ornithine decarboxylase | 0 | 0 | 0 | 2 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 1 | 8 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 1 | 2 |
| Protein kinase C beta type | 0 | 1 | 1 | 2 |
| Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
| Protein kinase C alpha type | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 0 | 1 | 1 |
| Protein kinase C iota type | 0 | 0 | 1 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 0 | 1 | 1 |
| Protein kinase C zeta type | 0 | 0 | 1 | 1 |
| Protein kinase C delta type | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 1 | 2 |
| Endothelial PAS domain-containing protein 1 | 0 | 0 | 1 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 0 | 1 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| Cytochrome P450 2D6 | 0 | 0 | 1 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 0 | 1 | 1 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |